Loading…
Loading…
EQUITY / NASDAQ · XNMS
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Shares
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗10.76 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 10.76 USD · Volume 205,557
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -261,958 USD | -269,810 USD | — |
| Net income | 1,604,621 USD | 1,874,343 USD | -14.39% |
| Cash and cash equivalents | 1,179,670 USD | — | — |
| Total liabilities | 8,748,581 USD | — | — |
| Total equity | -7,488,653 USD | -6,539,083 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,179,670 USD | — | — | 1,434,965 USD | 1,434,965 USD | 1,328,841 USD | — | — |
| Net incomeIncome statement | 1,604,621 USD | 2,998,742 USD | 1,394,121 USD | — | 7,288,824 USD | 1,966,742 USD | 5,499,876 USD | 1,874,343 USD |
| Operating profitIncome statement | -261,958 USD | -718,496 USD | — | — | -1,195,687 USD | -225,579 USD | -940,191 USD | -269,810 USD |
| Total assetsBalance sheet | 206,540,698 USD | — | — | 203,111,772 USD | 203,111,772 USD | 201,249,963 USD | — | — |
| Total equityBalance sheet | -7,488,653 USD | — | -7,226,695 USD | -6,770,157 USD | -6,770,157 USD | -6,764,662 USD | — | -6,539,083 USD |
| Total liabilitiesBalance sheet | 8,748,581 USD | — | — | 8,318,397 USD | 8,318,397 USD | 8,245,536 USD | — | — |
| Investing cash flowCash flow statement | — | 0 USD | — | — | 500,000 USD | — | 250,000 USD | — |
| Operating cash flowCash flow statement | — | -255,295 USD | — | — | -422,079 USD | — | -278,203 USD | — |
| Financing cash flowCash flow statement | — | — | — | — | 0 USD | — | — | — |
| Report source | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 03/26/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/12/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.